Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (81-90 of 173) with videos related to

Pageof 18
Sort By:
Journal of Cellular Physiology|May 18, 2019
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cellsClaudia Abbruzzese, Silvia Matteoni, Michele Persico, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulationMarco Radi, Lasse Evensen, Elena Dreassi, et al.
Pharmaceutics|June 27, 2025
Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma TreatmentLetizia Clementi, Federica Poggialini, Francesca Musumeci, et al.
Biofactors (Oxford, England)|August 9, 2017
Differentially activated Src kinase in chemo-naïve human primary osteosarcoma cells and effects of a Src kinase inhibitorMarcella Laschi, Giulia Bernardini, Michela Geminiani, et al.
Bioorganic Chemistry|May 1, 2025
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agentsChiara Vagaggini, Pasqualina D'Ursi, Federica Poggialini, et al.
European Journal of Medicinal Chemistry|March 18, 2008
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidinesSilvia Schenone, Chiara Brullo, Olga Bruno, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src InhibitorClaudia Contadini, Claudia Cirotti, Anna Carbone, et al.
Scientific Reports|March 31, 2017
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulationVincenzo Dattilo, Lucia D'Antona, Cristina Talarico, et al.
Journal of Cellular Physiology|February 9, 2017
The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cellsDomenico Conza, Paola Mirra, Gaetano Calì, et al.
Bioorganic & Medicinal Chemistry|May 22, 2003
Synthesis and antiproliferative activity of basic thioanalogues of merbaroneAngelo Ranise, Andrea Spallarossa, Silvia Schenone, et al.
Pageof 18

Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
Journal of Cellular Physiology|May 18, 2019
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cellsClaudia Abbruzzese, Silvia Matteoni, Michele Persico, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulationMarco Radi, Lasse Evensen, Elena Dreassi, et al.
Pharmaceutics|June 27, 2025
Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma TreatmentLetizia Clementi, Federica Poggialini, Francesca Musumeci, et al.
Biofactors (Oxford, England)|August 9, 2017
Differentially activated Src kinase in chemo-naïve human primary osteosarcoma cells and effects of a Src kinase inhibitorMarcella Laschi, Giulia Bernardini, Michela Geminiani, et al.
Bioorganic Chemistry|May 1, 2025
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agentsChiara Vagaggini, Pasqualina D'Ursi, Federica Poggialini, et al.
European Journal of Medicinal Chemistry|March 18, 2008
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidinesSilvia Schenone, Chiara Brullo, Olga Bruno, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src InhibitorClaudia Contadini, Claudia Cirotti, Anna Carbone, et al.
Scientific Reports|March 31, 2017
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulationVincenzo Dattilo, Lucia D'Antona, Cristina Talarico, et al.
Journal of Cellular Physiology|February 9, 2017
The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cellsDomenico Conza, Paola Mirra, Gaetano Calì, et al.
Bioorganic & Medicinal Chemistry|May 22, 2003
Synthesis and antiproliferative activity of basic thioanalogues of merbaroneAngelo Ranise, Andrea Spallarossa, Silvia Schenone, et al.
Pageof 18